Minute Insight: Agendia Collaborates With Illumina And Brazilian Health Care Providers
The company expects the major commercial collaboration and geographical roll-out will lead to increased adoption of Agendia’s breast cancer diagnostics.
You may also be interested in...
In this roundup feature focusing on new developments in digital health, Medtech Insight spotlights the push behind digital therapeutics, Abbott’s biowearable line, Exec Chats with iRhythm and Cognetivity, Right To Repair rules for tech, and FDA's guidance on 3D-printing.
NHSx has awarded Paige an undisclosed sum of money to support development of its AI-powered prostate cancer detection tool in clinical settings in the UK.
Guardant wants to become “one-stop-shop” in the cancer care continuum with the launch of an early-stage colorectal cancer test and planned launch of a tissue-based test.